Ariel Teper
- Immunology and Allergy top 0.5%
- Allergic Rhinitis and Sensitization 28
- Physiology top 1%
- Asthma and respiratory diseases 69
- Otorhinolaryngology top 2%
- Sinusitis and nasal conditions 7
- Dermatology top 2%
- Dermatology and Skin Diseases 15
- Immunology top 5%
- IL-33, ST2, and ILC Pathways 27
-
- Respiratory and Cough-Related Research 15
- Cystic Fibrosis Research Advances 10
-
- Eosinophilic Esophagitis 11
- Co-authors
- Neil M.H. GrahamGianluca PirozziLaurent EckertJorge MásperoBingzhi ZhangVijay N. JoishMario CastroJonathan Corren
- Journals
- Journal of Allergy and Clinical Immunology (21 papers)CHEST Journal (8 papers)Annals of Allergy Asthma & Immunology (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Ariel Teper
84 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Immunology and Allergy 801
- Physiology 1.4k
- Otorhinolaryngology 157
- Dermatology 262
- Immunology 542
Countries citing papers authored by Ariel Teper
This map shows the geographic impact of Ariel Teper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Teper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Teper more than expected).
Fields of papers citing papers by Ariel Teper
This network shows the impact of papers produced by Ariel Teper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Teper. The network helps show where Ariel Teper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ariel Teper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasisbreakdown → | 2025 | 26 |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 13 | |
| 11 | 2020 | 15 | |
| 12 | 2020 | 38 | |
| 13 | 2018 | 48 | |
| 14 | 2018 | 98 | |
| 15 | 2013 | 11 | |
| 16 | 2010 | 26 | |
| 17 | 2009 | 47 | |
| 18 | 2001 | 132 | |
| 19 | 2000 | 76 | |
| 20 | 2000 | 106 |
About Ariel Teper
Ariel Teper is a scholar working on Immunology and Allergy, Physiology, Dermatology, Otorhinolaryngology and Immunology, having authored 89 papers that have together received 1.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (69 papers), Allergic Rhinitis and Sensitization (28 papers), IL-33, ST2, and ILC Pathways (27 papers), Respiratory and Cough-Related Research (15 papers), Dermatology and Skin Diseases (15 papers), Eosinophilic Esophagitis (11 papers), Cystic Fibrosis Research Advances (10 papers) and Sinusitis and nasal conditions (7 papers). The work is most often cited by research in Immunology and Allergy (801 citations), Physiology (1.4k citations), Otorhinolaryngology (157 citations), Dermatology (262 citations) and Immunology (542 citations). Ariel Teper has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Neil M.H. Graham, Gianluca Pirozzi, Laurent Eckert, Jorge Máspero, Bingzhi Zhang, Vijay N. Joish, Mario Castro, Jonathan Corren, Sally E. Wenzel and Chih-Kang Huang. Their work appears in journals such as Journal of Allergy and Clinical Immunology, CHEST Journal, Annals of Allergy Asthma & Immunology, Advances in Therapy and Allergy and Asthma Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.